Skip to content

Public FDA record

Z-0117-2007: Abbott AxSYM Matrix Cells--Product List No: 8A73-02, sold in boxes of 100

Recall record Z-0117-2007 for Abbott Diagnostic International, Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0117-2007
Company in FDA record
Abbott Diagnostic International, Ltd.
FDA classification date
Nov 17, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Increase in complaints regarding controls out of range, calibration errors, and discrepant patient results with the AxSYM Troponin-I ADV assay.

Source facts

Initiated
2006-09-08
Root cause
Other
Terminated
2012-01-24
Distribution
Nationwide including the states of AL, AK, AZ, CA, CT, CO, DE, FL, GA, ID, IL, IA, IN, KS, KY, LA, MA, ME, MI, MS, MN, MT, MO, NM, NJ, NY, NV, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, Hawaii and Puerto Rico
Recall number
Z-0117-2007
Recall status
Terminated
CDRH record ID
48621
FDA classified
2006-11-17
Recall event number
36417

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗